文献速递糖尿病肥胖与代谢综合征

健康老年人空腹及糖负荷后GLP-1与GIP的纵向变化

Longitudinal Changes in Fasting and Glucose-Stimulated GLP-1 and GIP in Healthy Older Subjects.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

随访时空腹GLP-1、GIP及葡萄糖刺激的GLP-1均下降,胃排空T50减慢;空腹GIP及糖刺激GLP-1、GIP在两次研究间存在个体内相关。

要点

  • 健康老年人随访约5.9年后空腹GLP-1、GIP及糖刺激GLP-1下降。
  • 空腹GIP及糖刺激GLP-1、GIP在个体内保持相关,空腹GLP-1不相关。
  • 随访时胃排空T50减慢,但未确定为肠促胰素变化的影响因素。

核心结论

  • 健康老年人随访约5.9年后空腹GLP-1、空腹GIP及葡萄糖刺激的GLP-1浓度下降,葡萄糖刺激的GIP曲线面积无变化。
  • 空腹GIP及葡萄糖刺激的GLP-1、GIP浓度在个体内保持相关。
  • 作者认为增龄相关的GLP-1下降可能易感糖耐量异常和2型糖尿病。

研究设计与样本

  • 初次研究平均年龄71.2 ± 3.8(SD)岁。
  • 空腹及75g口服葡萄糖后测定血浆GLP-1和GIP,并收集呼气样本计算胃排空T50。

主要发现

  • 随访时空腹GLP-1浓度下降(P < 0.001),GLP-1 0至120分钟曲线下面积下降(P = 0.001)。
  • 随访时空腹GIP下降(P = 0.03),但GIP 0至120分钟曲线下面积无变化(P = 0.26)。
  • 随访时胃排空T50减慢(P = 0.008)。
  • 初次研究时T50变化或BMI均不是肠促胰素反应变化的影响因素。
  • 两次研究间空腹GIP相关(r = 0.72,P < 0.001),空腹GLP-1不相关(r = 0.23,P = 0.18);糖刺激GLP-1(r = 0.50,P = 0.002)和GIP(r = 0.60,P < 0.001)相关。

临床怎么用

  • 对健康老年人评估肠促胰素功能时,需考虑增龄相关的空腹GLP-1、GIP及糖刺激GLP-1下降。
  • 个体内空腹GIP及糖刺激GLP-1、GIP相对稳定,可为纵向监测提供参考。
  • 胃排空减慢与肠促胰素变化的关系尚需进一步研究,暂不能据此调整临床决策。

局限性

  • 观察性纵向研究,无法确定增龄与肠促胰素变化的因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: It is not known whether glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) levels correlate within individuals, nor whether levels change with age. Previous studies have all been cross-sectional in design. OBJECTIVE: To evaluate longitudinal changes in fasting and glucose-stimulated incretin hormone concentrations in healthy older subjects. PATIENTS AND DESIGN: Forty-one healthy older subjects had measurements of plasma GLP-1 and GIP while fasting and after a 75-g oral glucose load on two occasions separated by 5.9 ± 0.1 years [mean age at the initial study: 71.2 ± 3.8 (SD) years]. Breath samples were collected to calculate the gastric 50% emptying time (T50). RESULTS: For GLP-1, both fasting concentrations (P < 0.001) and area under the curve 0 to 120 minutes (P = 0.001) were decreased at followup. Fasting GIP was also lower (P = 0.03) at follow up, but there was no change in the area under the curve 0 to 120 minutes (P = 0.26). The gastric emptying T50 was slower at followup (P = 0.008). Neither the change in T50 nor the body mass index at the initial study was a determinant of the change in incretin responses. Between the two study days, fasting GIP (r = 0.72, P < 0.001) correlated well, but not fasting GLP-1 (r = 0.23, P = 0.18). However, both glucose-stimulated GLP-1 (r = 0.50, P = 0.002) and GIP (r = 0.60, P < 0.001) showed correlations between the initial and follow-up studies. CONCLUSIONS: Fasting GIP and glucose-stimulated GLP-1 and GIP concentrations correlate within individuals over a follow-up period of ∼5.9 years. Aging is associated with reductions in fasting GLP-1 and GIP, and glucose-stimulated GLP-1, which may predispose to the development of glucose intolerance and type 2 diabetes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Pham H, Marathe CS, Phillips LK, et al. Longitudinal Changes in Fasting and Glucose-Stimulated GLP-1 and GIP in Healthy Older Subjects. J Clin Endocrinol Metab. 2019. PMID: 31393567. doi:10.1210/jc.2019-01262

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。